Broad Institute

From WikiMD's WELLNESSPEDIA

Broad Institute is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is a collaboration between Massachusetts Institute of Technology (MIT), Harvard University, Harvard Medical School, and the five Harvard-affiliated hospitals. The Broad Institute aims to improve human health by using genomics to advance our understanding of the biology and treatment of human disease.

History[edit]

The Broad Institute was launched in 2004, with a $100 million commitment from philanthropists Eli and Edythe Broad. The institute was officially established as an independent nonprofit organization in 2009. The Broad Institute has made significant contributions to the field of genomics and has been instrumental in various large-scale, collaborative research projects, such as the Human Genome Project and the Cancer Genome Atlas.

Research[edit]

The Broad Institute conducts research in a wide range of areas, including cancer, cardiovascular disease, diabetes, psychiatric disorders, and infectious diseases. The institute's research is characterized by its interdisciplinary approach, combining expertise in biology, chemistry, computer science, medicine, and statistics to tackle complex challenges in human health.

Facilities[edit]

The Broad Institute's facilities include state-of-the-art laboratories, high-throughput sequencing centers, and advanced computational resources. The institute also houses the Broad Institute Data Sciences Platform, which provides a suite of software tools and services to support data-intensive biomedical research.

Collaborations[edit]

The Broad Institute collaborates with a global network of researchers and institutions. These collaborations aim to accelerate the pace of scientific discovery and translate findings into new treatments and therapies.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.